sudden sensorineural hearing loss
Jump to navigation
Jump to search
Etiology
- viral infection
- drug reaction
- acoustic neuroma
- multiple sclerosis
- head injury
- vascular disease
- autoimmune disease
- Meniere's disease
- idiopathic 90%
Clinical manifestations
Diagnostic procedures
Radiology
- MRI neuroimaging to exclude tumor, multiple sclerosis, vascular disease
Management
- refer to otolaryngologist
- glucocorticoids (evidence lacking)[1][2]
- ref[3] NEJM) claims high-dose oral prednisone effective if initiated within 7-10 days
- intravenous prednisolone 250 mg or oral dexamethasone 40 mg for 5 days no more effective than prednisone 60 mg for 5 days followed by 5 day taper[4]
More general terms
References
- ↑ 1.0 1.1 Medical Knowledge Self Assessment Program (MKSAP) 18, American College of Physicians, Philadelphia 2018
- ↑ 2.0 2.1 Wei BP, Stathopoulos D, O'Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev. 2013 Jul 2;2013(7):CD003998. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23818120 PMCID: PMC7390468 Free PMC article
- ↑ 3.0 3.1 NEJM Knowledge+ Otolaryngology
- ↑ 4.0 4.1 Plontke SK et al. High-dose glucocorticoids for the treatment of sudden hearing loss. NEJM Evid 2024 Jan; 3:EVIDoa2300172. PMID: https://www.ncbi.nlm.nih.gov/pubmed/38320514 Clinical Trial. https://evidence.nejm.org/doi/10.1056/EVIDoa2300172